Skip to content
Immunai homepage
Main Navigation
  • Solutions
  • Platform
  • Company
  • Careers
  • Resources
    • Articles
    • Podcasts
    • Press Releases
    • Publications
    • Video
Secondary Navigation
  • Contact
Mobile Navigation
  • Solutions
  • Platform
  • Company
  • Careers
  • Resources
    • Articles
    • Podcasts
    • Press Releases
    • Publications
    • Video
  • Contact
  • All
  • Articles
  • Podcasts
  • Press Releases
  • Publications
  • Video

Resources (71)

Video
06/19/2025

Immunai’s journey to smarter oncology drug development

Video
06/19/2025

How Immunai and AstraZeneca are reshaping drug discovery in IBD

Immunai will generate a publicly accessible multi-omic dataset for a cohort of over 1,000 patients treated with standard-of-care immunotherapy from the Parker Institute
04/24/2025

Immunai and Parker Institute to Build Massive Cancer Single-Cell Dataset

Press Releases
03/06/2025

Immunai Appoints Former Pfizer CSO and R&D Chief, Mikael Dolsten to Board of Directors

Articles
02/05/2025

Immunai Named Startup of the Week by the Innovator

Articles
01/16/2025

Is AI Failing Drug Development? The Unseen Challenges

Articles
01/05/2025

5 Ways this Startup Puts Values in Action

Articles
12/09/2024

Immunai is named one of the 25 techbio leaders shaping the AI-biology convergence in 2024 by Research & Development World

Next

Navigation

  • Home
  • Solutions
  • Platform
  • Company
  • Careers
  • Resources
  • Contact

Contact

430 E 29th St,
New York, NY 10016, USA
info@immunai.com

Press Inquiries

press@immunai.com

Follow Us

  • Cookie Notice
  • Privacy Policy
Copyright © 2025 Immunai

We've revised our Privacy Policy and Cookie Notice. By accepting, you agree to our updated terms and policies.

Accept
Instant Access

Please share a few details and a download link will appear below.

    Thank you! Download the PDF here.